Herrmann F - Search Results

1

Hematopoietic growth factors in oncology.

Mertelsmann R, Lindemann A, Oster W, Gamm H, Kolbe K, Herrmann F. Mertelsmann R, et al. Among authors: herrmann f. Cancer Detect Prev. 1990;14(6):613-6. Cancer Detect Prev. 1990. PMID: 2257558 Review.

2

Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.

Brach MA, Gruss HJ, Asano Y, de Vos S, Ludwig WD, Mertelsmann R, Herrmann F. Brach MA, et al. Among authors: herrmann f. Cancer Res. 1992 Apr 15;52(8):2197-201. Cancer Res. 1992. PMID: 1373106

3

Hematopoietic growth factors in bone marrow transplantation.

Mertelsmann R, Herrmann F, Hecht T, Schulz G. Mertelsmann R, et al. Among authors: herrmann f. Bone Marrow Transplant. 1990 Aug;6(2):73-7. Bone Marrow Transplant. 1990. PMID: 1698494 Review.

4

Clinical evaluation of hematopoietic growth factors.

Lindemann A, Herrmann F, Mertelsmann R. Lindemann A, et al. Among authors: herrmann f. Adv Exp Med Biol. 1991;297:93-102. doi: 10.1007/978-1-4899-3629-5_8. Adv Exp Med Biol. 1991. PMID: 1767757 Review. No abstract available.

5

Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.

Herrmann F, Mertelsmann R, Lindemann A, Ottmann OG, Seipelt G, Oster W, Hoelzer D, Ganser A. Herrmann F, et al. Biotechnol Ther. 1991;2(3-4):299-311. Biotechnol Ther. 1991. PMID: 1845132 Clinical Trial.

6

Screening for expression of cytokines with hematopoietic growth factor activity by permanent human B-cell lines.

Lindemann A, Dörken B, Henschler R, Mertelsmann R, Herrmann F. Lindemann A, et al. Among authors: herrmann f. Leukemia. 1991 Aug;5(8):715-8. Leukemia. 1991. PMID: 1886424

7

Hemopoietins in clinical oncology.

Kanz L, Lindemann A, Oster W, Herrmann F, Mertelsmann R. Kanz L, et al. Among authors: herrmann f. Am J Clin Oncol. 1991;14 Suppl 1:S27-33. doi: 10.1097/00000421-199112001-00006. Am J Clin Oncol. 1991. PMID: 2048561 Review.

8

Control of blast cell proliferation and differentiation in acute myelogenous leukemia by soluble polypeptide growth factors.

Herrmann F, Oster W, Mertelsmann R. Herrmann F, et al. Klin Padiatr. 1990 Jul-Aug;202(4):212-7. doi: 10.1055/s-2007-1025522. Klin Padiatr. 1990. PMID: 2203937 Review.

9

High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia.

Lindemann A, Ludwig WD, Oster W, Mertelsmann R, Herrmann F. Lindemann A, et al. Among authors: herrmann f. Blood. 1989 Mar;73(4):880-4. Blood. 1989. PMID: 2920210 Free article.

10

Modulation of cytotoxicity and differentiation-inducing potential of arabinofuranosylcytosine in myeloid leukemia cells by hematopoietic cytokines.

Brach MA, Mertelsmann RH, Herrmann F. Brach MA, et al. Among authors: herrmann f. Cancer Invest. 1993;11(2):198-211. doi: 10.3109/07357909309024840. Cancer Invest. 1993. PMID: 8462021 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,204 results

Search Page

Filters